Content about Business Relation

November 3, 2011

At a press conference organized by the Preserve Community Pharmacy Access NOW! coalition at the Capitol on Thursday morning, the National Community Pharmacists Association's CEO Douglas Hoey issued a statement regarding the proposed merger of pharmacy benefit managers Express Scripts and Medco Health Solutions, saying the deal could mean "more wasteful mail-order spending and higher price spikes for specialty drugs."

WASHINGTON — At a press conference organized by the Preserve Community Pharmacy Access NOW! coalition at the Capitol on Thursday morning, the National Community Pharmacists Association's CEO Douglas Hoey issued a statement regarding the proposed merger of pharmacy benefit managers Express Scripts and Medco Health Solutions, saying the deal could mean "more wasteful mail-order spending and higher price spikes for specialty drugs."

October 28, 2011

Aramis and Designer Fragrances, a division of Estée Lauder, and Tory Burch LLC have inked a multiyear agreement for the exclusive worldwide license of the Tory Burch fragrance business. This partnership marks Tory Burch’s first foray into the beauty industry.

NEW YORK — Aramis and Designer Fragrances, a division of Estée Lauder, and Tory Burch LLC have inked a multiyear agreement for the exclusive worldwide license of the Tory Burch fragrance business. This partnership marks Tory Burch’s first foray into the beauty industry.

October 27, 2011

Drug makers Bristol-Myers Squibb and Gilead Sciences announced an agreement to develop and commercialize a fixed-dose combination treatment for patients with HIV.

FOSTER CITY, Calif. — Drug makers Bristol-Myers Squibb and Gilead Sciences announced an agreement to develop and commercialize a fixed-dose combination treatment for patients with HIV.

The two companies said the drug will combine Bristol's Reyataz (atazanavir sulfate) and Gilead's boosting agent cobicistat, which is designed to increase blood levels of certain HIV medicines to potentially allow for one-pill, once-daily dosing. Gilead is currently studying Reyataz and cobicistat in phase-2 and phase-3 trials.

October 19, 2011

Technology in retail pharmacies has traditionally 
meant the adoption of robotic dispensing systems and electronic health records, but in recent years, pharmacy retailers have been bringing technology to the consumer level.


Technology in retail pharmacies has traditionally 
meant the adoption of robotic dispensing systems and electronic health records, but in recent years, pharmacy retailers have been bringing technology to the consumer level.


In September, Rite Aid teamed up with OptumHealth to become the first to provide “virtual clinics” in a retail pharmacy setting in some stores in the Detroit area.


October 6, 2011

Gilead Sciences has signed an agreement with Boehringer Ingelheim to gain exclusive worldwide rights to research, develop and commercialize BI's novel anti-retroviral compounds.

FOSTER CITY, Calif., and INGELHEIM, Germany — Gilead Sciences has signed an agreement with Boehringer Ingelheim to gain exclusive worldwide rights to research, develop and commercialize BI's novel anti-retroviral compounds.

Under the terms of the agreement, Gilead will pay the German drug maker an upfront payment and possibly will receive additional payments based upon the achievement of certain development, regulatory and commercial milestones, as well as royalties on future net sales, the companies said.

October 6, 2011

German drug maker Merck KGaA will collaborate with Japanese drug maker Ono Pharmaceutical to develop oral therapies for cancer and multiple sclerosis, Merck KGaA said.

DARMSTADT, Germany — German drug maker Merck KGaA will collaborate with Japanese drug maker Ono Pharmaceutical to develop oral therapies for cancer and multiple sclerosis, Merck KGaA said.

October 3, 2011

CVS/pharmacy has teamed up with Aetna to offer Medicare beneficiaries a co-branded prescription drug plan.

HARTFORD, Conn. — CVS/pharmacy has teamed up with Aetna to offer Medicare beneficiaries a co-branded prescription drug plan.

The companies said the new Aetna CVS/pharmacy Prescription Drug Plan will be made available to beneficiaries in 43 states and Washington, D.C. The plan offers a $26 monthly plan premium and has no deductible for generic drugs. In addition, members will have the following benefits when they fill their prescriptions at a CVS/pharmacy (compared with a nonpreferred network pharmacy):

September 28, 2011

Rite Aid announced Wednesday the launch of the first extension of its Wellness+ loyalty card program.

CAMP HILL, Pa. — Rite Aid announced Wednesday the launch of the first extension of its Wellness+ loyalty card program.

Offered free to members, Wellness+ for Diabetes is described as a multifaceted program that offers exclusive resources and savings to people living with diabetes and their caregivers.

September 21, 2011

The offering period for Pfizer's acquisition of Icagen has expired, allowing the former to purchase more than 5 million shares in the company, Pfizer said.

NEW YORK — The offering period for Pfizer's acquisition of Icagen has expired, allowing the former to purchase more than 5 million shares in the company, Pfizer said.

Pfizer said that as of Monday, 5.4 million shares of Icagen had been put up for sale. Along with the 1.1 million shares Pfizer already owns, this would give it control of 70.2% of Icagen, which develops drugs for pain and other conditions. Pfizer plans to acquire the remaining shares as well.

September 20, 2011

One day after the National Association of Chain Drug Stores launched a radio ad in the Washington, D.C., market that warned of the potential consequences of the merger between pharmacy benefit managers Express Scripts and Medco, the PBMs have debuted their own ad, which seeks to highlight the benefits of the deal.

WASHINGTON — One day after the National Association of Chain Drug Stores launched a radio ad in the Washington, D.C., market that warned of the potential consequences of the merger between pharmacy benefit managers Express Scripts and Medco, the PBMs have debuted their own ad, which seeks to highlight the benefits of the deal.

September 12, 2011

The Generic Pharmaceutical Association has named Ralph Neas as its new president and CEO.

EXECUTIVE NEWS — The Generic Pharmaceutical Association has named Ralph Neas as its new president and CEO. Neas, currently president and CEO of the National Coalition on Health Care, replaces Kathleen Jaeger, who stepped down as president and CEO of GPhA in May 2010 after eight years with the organization. The GPhA said it planned to spend September introducing Neas to stakeholders in a broad outreach effort.


September 9, 2011

At a special meeting held Friday, BJ's Wholesale Club stockholders approved the definitive agreement between the company and Leonard Green & Partners and CVC Capital Partners to be acquired in an all-cash transaction valued at about $2.8 billion.

WESTBOROUGH, Mass. — At a special meeting held Friday, BJ's Wholesale Club stockholders approved the definitive agreement between the company and Leonard Green & Partners and CVC Capital Partners to be acquired in an all-cash transaction valued at about $2.8 billion.

BJ's anticipates the closing of the transaction, which was announced in late June, will occur around the end of the month.

September 9, 2011

If this were a fist-fight, you might say Express Scripts just took the old "one-two" to the jaw — though in this case, the punches came from two different directions.

WHAT IT MEANS AND WHY IT'S IMPORTANT — If this were a fist-fight, you might say Express Scripts just took the old "one-two" to the jaw — though in this case, the punches came from two different directions.

(THE NEWS: Walgreens makes case of value outside of Express Scripts in SEC filing. For the full story, click here)

September 9, 2011

Stop & Shop has teamed up with Unilever to support the hunger relief efforts of Feeding America and its local member food banks.

QUINCY, Mass. — Stop & Shop has teamed up with Unilever to support the hunger relief efforts of Feeding America and its local member food banks.

The companies said that they are donating $150,000 to the organization, which will provide more than 1 million meals to families in need.

August 25, 2011

A new agreement between Innovation and RxSafe allows Innovation to distribute RxSafe's line of automated, high-density robotic storage and retrieval systems for pharmacies, the two companies said.

JOHNSON CITY, N.Y. — A new agreement between Innovation and RxSafe allows Innovation to distribute RxSafe's line of automated, high-density robotic storage and retrieval systems for pharmacies, the two companies said.

Innovation makes the PharmASSIST line of pharmacy automation products, while RxSafe makes the RxSafe and RxVault systems.

August 22, 2011

Prasco will market an authorized generic drug for urinary tract infections under an agreement with Shionogi, the company said Monday.

CINCINNATI — Prasco will market an authorized generic drug for urinary tract infections under an agreement with Shionogi, the company said Monday.

Prasco announced that it signed a supply agreement with Shinogi to market and distribute nitrofurantoin oral suspension, an authorized generic version of Furadantin. Authorized generics are branded drugs marketed under their generic names at a discounted price, usually through a third-party company, such as Prasco.

August 15, 2011

Elizabeth Arden has amended its long-term license agreement with Liz Claiborne to acquire the trademarks for the Curve fragrance brands and selected other smaller fragrance brands.

NEW YORK — Elizabeth Arden has amended its long-term license agreement with Liz Claiborne to acquire the trademarks for the Curve fragrance brands and selected other smaller fragrance brands.

The amendment also includes a lower effective royalty rate for the remaining licensed fragrance brands, including Juicy Couture and Lucky Brand fragrances, reduces the future minimum guaranteed royalties for the term of the license and requires a pre-payment of royalties for the remainder of calendar 2011.

August 11, 2011

CVS Caremark’s MinuteClinic continues to expand its list of strategic alliances, with its latest partner being Indiana University Health (IU Health), the largest health system in Indiana.

WOONSOCKET, R.I. — CVS Caremark’s MinuteClinic continues to expand its list of strategic alliances, with its latest partner being Indiana University Health (IU Health), the largest health system in Indiana.

July 28, 2011

Pfizer has entered a definitive agreement to acquire a biopharmaceutical company that focuses on the development of pain treatments.

NEW YORK — Pfizer has entered a definitive agreement to acquire a biopharmaceutical company that focuses on the development of pain treatments.

Pfizer, which currently owns a near 11% stake in Icagen, will acquire the company's remaining 8.3 million shares. The aggregate transaction value, which includes the value of the shares currently owned by Pfizer, is about $56 million.

The two companies entered a discovery, development and commercialization collaboration in 2007, which sought to create potential treatments for pain and related disorders.

July 27, 2011

Slice, a maker of cutting tools for home, school, office and industry, has announced that it will debut at the upcoming Cosmoprof North America in Las Vegas a line of new beauty tools designed by architect and designer Michael Graves.

SAN FRANCISCO — Slice, a maker of cutting tools for home, school, office and industry, has announced that it will debut at the upcoming Cosmoprof North America in Las Vegas a line of new beauty tools designed by architect and designer Michael Graves.
 
The initial 12 designs are the result of a two-year collaboration between Slice and Graves, and include six different models of tweezers, nail scissors, cuticle scissors, fingernail clippers, toenail clippers, a ceramic nail file and cosmetic pencil sharpener.
 

July 20, 2011

Canadian drug maker Valeant Pharmaceuticals International has signed an agreement with Sanofi’s subsidiary in Canada to distribute a topical medication for osteoarthritis in the country.

MISSISSAUGA, Ontario — Canadian drug maker Valeant Pharmaceuticals International has signed an agreement with Sanofi’s subsidiary in Canada to distribute a topical medication for osteoarthritis in the country.

Valeant said Tuesday that it had reached an agreement with Sanofi-Aventis Canada for Canadian marketing and distribution rights to Zuacta (zucapsaicin), designed for treating osteoarthritis of the knee.

July 14, 2011

Eli Lilly & Co. and Disney are collaborating to produce a dedicated lifestyle website and publications for families affected by Type 1 diabetes, the two companies said Thursday.

INDIANAPOLIS — Eli Lilly & Co. and Disney are collaborating to produce a dedicated lifestyle website and publications for families affected by Type 1 diabetes, the two companies said Thursday.

June 22, 2011

The Soho brand, which is known for its soft-sided cosmetic bags and beauty cases, now is expanding into makeup brushes with a collection of ergonomically designed brushes for the mass market.

LOS ANGELES — The Soho brand, which is known for its soft-sided cosmetic bags and beauty cases, now is expanding into makeup brushes with a collection of ergonomically designed brushes for the mass market.

For spring 2012, Soho will release a new ergonomically designed, 18-piece collection of brushes developed in partnership with makeup artists and designers.

June 21, 2011

Walgreens on Tuesday announced the company no longer will participate in the Express Scripts network beginning Jan. 1, 2012, citing unsuccessful renewal negotiations.

DEERFIELD, Ill. — Walgreens on Tuesday announced the company no longer will participate in the Express Scripts network beginning Jan. 1, 2012, citing unsuccessful renewal negotiations.

June 17, 2011

Leonard Green & Partners and CVC Capital Partners said Friday they are making a joint buyout bid worth an undisclosed amount for BJ's Wholesale Club.

NEW YORK — Leonard Green & Partners and CVC Capital Partners said Friday they are making a joint buyout bid worth an undisclosed amount for BJ's Wholesale Club.

The two private equity firms revealed their plans in a Securities and Exchange Commission filing on Friday. The bid price was not disclosed.

In February, BJ's announced it was exploring a sale. In March, Leonard Green already is the chain's larger shareholder, with a 9.3% stake.